English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Predictors of neuropsychiatric side effects and therapy response of dopamine agonist therapy in patients with prolactinomas: a clinical study concept

MPS-Authors
/persons/resource/persons124315

Athanasoulia,  A.
AG Stalla, Günter, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80528

Sievers,  C.
AG Stalla, Günter, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80379

Ising,  M.
AG Ising, Marcus, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80563

Uhr,  M.
AG Uhr, Manfred, Florian Holsboer (Direktor), Max Planck Institute of Psychiatry, Max Planck Society;

Stalla,  G. K.
Max Planck Institute of Psychiatry, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Athanasoulia, A., Sievers, C., Ising, M., Uhr, M., & Stalla, G. K. (2009). Predictors of neuropsychiatric side effects and therapy response of dopamine agonist therapy in patients with prolactinomas: a clinical study concept. Experimental and Clinical Endocrinology & Diabetes, 117(10), 660-660.


Cite as: http://hdl.handle.net/11858/00-001M-0000-000E-9170-3
Abstract
There is no abstract available